Polypharmacy

Drug Therapy for the Elderly

Volumn 9783709109120, Issue , 2013, Pages 319-329

  Burkhardt, Heinrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930591515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0912-0_26     Document Type: Chapter

References (31)

1. Balducci L, Extermann M (2000) Management of cancer in the older person: A practical approach. Oncologist 5:224-237
2. Balducci L, Colloca G, Cesari M, Gambassi G (2010) Assessment and treatment of elderly patients with cancer. Surg Oncol 19:117-123
3. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531-1536
4. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294:716-724
5. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN (2008) Polypharmacy: misleading, but manageable. Clin Interv Aging 3:383-389
6. Chutka DS, Takahashi PY, Hoel RW (2004) Inappropriate medications for elderly patients. Mayo Clin Proc 79:122-139
7. Fick DM, Waller JL, Maclean JR et al (2001) Potentially inappropriate medication use in a managed care population: association with higher costs and utilization. J Manag Care Pharm 7:407-413
8. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a U.S. consensus panel of experts. Arch Intern Med 163:2716-2724
9. Flockhart DA (2007) Drug interactions: cytochrome P450 drug interaction table. Indiana University School of Medicine. http://medicine.iupui.edu/clinpharm/ddis/ table.aspx. Accessed 7 Oct 2011
10. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): consensus validation. Int J Clin Pharmacol Ther 46:72-83
11. Garfinkel D, Zur-Gil S, Ben-Israel J (2007) The war against polypharmacy: A new cost-effective geriatricpalliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 9:430-434
12. Gillick MR (2006) The denial of aging. Harvard University Press, Cambridge
13. Glaeske G, Hoffmann F (2009) Der Wettbewerb der Leitlinien bei alteren Menschen-Multimorbiditat und Polypharmazie als Problem. Neuro Geriatrie 6:115-119
14. in German Gurwitz JH (2004) Polypharmacy. A new paradigm for quality drug therapy in the elderly? Arch Intern Med 164:1957-1959
15. Hanlon JT, Fillenbaum GG, Kuchibhatla M et al (2002) Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 40:166-176
16. Holt S, Schmiedl S, Thurmann PA (2010) Potentially inappropriate medications in the elderly: The PRISCUS list. Dtsch Arztebl Int 107:543-551
17. Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: A French consensus panel list. Eur J Clin Pharmacol 63:725-731
18. Maio V, Del Canale S, Abouzaid S, Investigators GAP (2010) Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: A cohort study. J Clin Pharm Ther 35:219-229
19. National Center for Health Statistics (1996) National Health and Nutrition Examination Survey (NHANES) III. http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed 11 Jan 2010
20. Palareti G, Legnani C (1996) Warfarin withdrawal-pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 30:300-313
21. Podrazik PM, Schwartz JB (1999) Cardiovascular pharmacology of aging. Cardiol Clin 17:17-34
22. Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Grégoire JP (2004) Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 4:9
23. Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: The prescribing cascade. BMJ 315:1096-1099
24. Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27:153-159
25. Rollason V, Vogt N (2003) Reduction of polypharmacy in the elderly. Drugs Aging 20:817-832
26. Semla TP, Beizer JL, Higbee MD (2011) Geriatric dosage handbook. LexiComp, Hudson
27. Steinhagen-Thiessen E, Borchelt M (2001) Morbidity, medication, and functional limitations in very old age. In: Baltes PB (ed) The Berlin aging study, aging from 70 to 100. Cambridge University Press, Cambridge, UK
28. Stuck A, Kharicha K, Dapp U et al (2007) Development, feasibility and performance of a health risk appraisal questionnaire for older persons. BMC Med Res Methodol 7:1
29. Wedding U, Honecker F, Bokemeyer C, Pientka L, Hoffken K (2007) Tolerance to chemotherapy in elderly patients with cancer. Cancer Control 14:44-56
30. Wehling M (2011) Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 59:376-377
31. Winit-Watjana W, Sakulrat P, Kespichayawattana J (2007) Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr 47:35-51